XTLB logo

XTL Biopharmaceuticals (XTLB) Selling, General & Administrative Expenses

Annual SGA

$734.00 K
-$116.00 K-13.65%

December 31, 2023

Summary

Performance

1-Year Change

-13.65%

3-Year Change

-19.34%

5-Year Change

-2.78%

15-Year Change

-38.99%

XTLB SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.72%
XTLB annual SGA is higher than 0.72% of companies in Healthcare sector

High & Low

All-time High

$5.58 M
XTLB annual SGA is currently -86.85% below its historical high of $5.58 million

3-Year Low

$734.00 K
XTLB annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
XTLB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 30, 2025
XTLB next annual earnings announcement is scheduled for Apr 30, 2025

OtherXTLBexpensesmetrics:

Annual Total Expenses

$765.00 K
XTLB annual total expenses is $765.00 thousand

Annual Operating Expenses

$765.00 K
XTLB annual total operating expenses is $765.00 thousand

Annual Cost Of Goods Sold

-
XTLB annual cost of goods sold value is unknown

Annual Interest Expense

-
XTLB annual interest expense value is unknown

Quarterly SGA

$756.00 K
+$341.00 K+82.17%

September 30, 2024

Summary

Performance

3-Month Change

+82.17%

1-Year Change

+347.34%

3-Year Change

+347.34%

5-Year Change

+268.78%

XTLB Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.44%
XTLB quarterly SGA is higher than 2.44% of companies in Healthcare sector

High & Low

All-time High

$1.65 M
XTLB quarterly SGA is currently -54.07% below its historical high of $1.65 million

3-Year Low

$145.00 K
XTLB quarterly SGA is currently +421.38% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XTLB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
XTLB next earnings announcement is scheduled for Apr 30, 2025

OtherXTLBexpensesmetrics:

Quarterly Total Expenses

$926.00 K
XTLB quarterly total expenses is $926.00 thousand

Quarterly Operating Expenses

$810.00 K
XTLB quarterly total operating expenses is $810.00 thousand

Quarterly Cost Of Goods Sold

-
XTLB quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$93.00 K
XTLB quarterly interest expense is $93.00 thousand

TTM SGA

-$633.01 M
-$801.00 K-0.13%

September 30, 2024

Summary

Performance

3-Month Change

-68681.37%

1-Year Change

-95288.87%

3-Year Change

-95288.87%

5-Year Change

-70355.94%

XTLB TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.76%
XTLB TTM SGA is higher than 56.76% of companies in Healthcare sector

High & Low

All-time High

-$79.37 M

3-Year Low

-$633.01 M
XTLB TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
XTLB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
XTLB next earnings announcement is scheduled for Apr 30, 2025

OtherXTLBexpensesmetrics:

Annual Total Expenses

$765.00 K
XTLB annual total expenses is $765.00 thousand

Annual Operating Expenses

$765.00 K
XTLB annual total operating expenses is $765.00 thousand

TTM Cost Of Goods Sold

-
XTLB TTM cost of goods sold value is unknown

TTM Interest Expense

$122.00 K
XTLB TTM interest expense is $122.00 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$734.00 K
XTLB annual SGA is $734.00 thousand

Annual Operating Expenses

$765.00 K
XTLB annual total operating expenses is $765.00 thousand

Annual Cost Of Goods Sold

-
XTLB annual cost of goods sold value is unknown

XTLB Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.7%+347.3%-10000.0%
3 y3 years-19.3%+347.3%-10000.0%
5 y5 years-2.8%+268.8%-10000.0%

XTLB Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-26.7%at lowat high+421.4%-104.2%at low
5 y5-year-26.7%at lowat high+421.4%-314.5%at low
alltimeall time-86.8%+130.2%-54.1%+114.7%-697.5%at low

XTL Biopharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$756.00 K(+82.2%)
$1.53 M(+66.2%)
Jun 2024
-
$415.00 K(+145.6%)
$923.00 K(+38.8%)
Mar 2024
-
$169.00 K(-12.9%)
$665.00 K(-9.4%)
Dec 2023
$734.00 K(-13.6%)
$194.00 K(+33.8%)
$734.00 K(-3.3%)
Sep 2023
-
$145.00 K(-7.6%)
$759.00 K(-6.9%)
Jun 2023
-
$157.00 K(-34.0%)
$815.00 K(-3.6%)
Mar 2023
-
$238.00 K(+8.7%)
$845.00 K(-0.6%)
Dec 2022
$850.00 K(-15.1%)
$219.00 K(+9.0%)
$850.00 K(-6.7%)
Sep 2022
-
$201.00 K(+7.5%)
$911.00 K(-0.3%)
Jun 2022
-
$187.00 K(-23.0%)
$914.00 K(-10.7%)
Mar 2022
-
$243.00 K(-13.2%)
$1.02 M(+2.3%)
Dec 2021
$1.00 M(+10.0%)
$280.00 K(+37.3%)
$1.00 M(+3.6%)
Sep 2021
-
$204.00 K(-31.3%)
$966.00 K(-0.1%)
Jun 2021
-
$297.00 K(+35.0%)
$967.00 K(+10.4%)
Mar 2021
-
$220.00 K(-10.2%)
$876.00 K(-3.7%)
Dec 2020
$910.00 K(+12.8%)
$245.00 K(+19.5%)
$910.00 K(+1.0%)
Sep 2020
-
$205.00 K(-0.5%)
$901.00 K(+1.7%)
Jun 2020
-
$206.00 K(-18.9%)
$886.00 K(+1.7%)
Mar 2020
-
$254.00 K(+7.6%)
$871.00 K(+7.9%)
Dec 2019
$807.00 K(+6.9%)
$236.00 K(+24.2%)
$807.00 K(+3.1%)
Sep 2019
-
$190.00 K(-0.5%)
$783.00 K(+1.2%)
Jun 2019
-
$191.00 K(+0.5%)
$774.00 K(+2.1%)
Mar 2019
-
$190.00 K(-10.4%)
$758.00 K(+0.4%)
Dec 2018
$755.00 K(-37.2%)
$212.00 K(+17.1%)
$755.00 K(-9.4%)
Sep 2018
-
$181.00 K(+3.4%)
$833.00 K(0.0%)
Jun 2018
-
$175.00 K(-6.4%)
$833.00 K(-23.3%)
Mar 2018
-
$187.00 K(-35.5%)
$1.09 M(-9.7%)
Dec 2017
$1.20 M(-5.3%)
$290.00 K(+60.2%)
$1.20 M(-0.2%)
Sep 2017
-
$181.00 K(-57.7%)
$1.21 M(-6.5%)
Jun 2017
-
$428.00 K(+40.8%)
$1.29 M(+7.0%)
Mar 2017
-
$304.00 K(+4.1%)
$1.21 M(-5.1%)
Dec 2016
$1.27 M(-10.1%)
$292.00 K(+10.2%)
$1.27 M(-8.1%)
Sep 2016
-
$265.00 K(-23.0%)
$1.38 M(+0.2%)
Jun 2016
-
$344.00 K(-6.8%)
$1.38 M(-4.7%)
Mar 2016
-
$369.00 K(-8.7%)
$1.45 M(+2.5%)
Dec 2015
$1.41 M
$404.00 K(+54.2%)
$1.41 M(-4.9%)
Sep 2015
-
$262.00 K(-36.4%)
$1.48 M(-4.2%)
Jun 2015
-
$412.00 K(+23.4%)
$1.55 M(+2.9%)
DateAnnualQuarterlyTTM
Mar 2015
-
$334.00 K(-29.8%)
$1.51 M(-12.4%)
Dec 2014
$1.72 M(+34.1%)
$476.00 K(+45.6%)
$1.72 M(-368.2%)
Sep 2014
-
$327.00 K(-11.4%)
-$641.00 K(+30.8%)
Jun 2014
-
$369.00 K(-32.5%)
-$490.00 K(-210.6%)
Mar 2014
-
$547.00 K(-129.0%)
$443.00 K(-65.4%)
Dec 2013
$1.28 M(-46.6%)
-$1.88 M(-494.1%)
$1.28 M(-63.2%)
Sep 2013
-
$478.00 K(-63.3%)
$3.48 M(-15.3%)
Jun 2013
-
$1.30 M(-6.1%)
$4.11 M(+20.9%)
Mar 2013
-
$1.39 M(+340.0%)
$3.40 M(+41.8%)
Dec 2012
$2.40 M(+133.4%)
$315.00 K(-71.6%)
$2.40 M(+2.0%)
Sep 2012
-
$1.11 M(+87.6%)
$2.35 M(+57.5%)
Jun 2012
-
$591.00 K(+53.9%)
$1.49 M(+30.9%)
Mar 2012
-
$384.00 K(+42.8%)
$1.14 M(+8.9%)
Dec 2011
$1.03 M(-15.9%)
$269.00 K(+7.6%)
$1.05 M(-0.5%)
Sep 2011
-
$250.00 K(+5.0%)
$1.05 M(-4.2%)
Jun 2011
-
$238.00 K(-18.2%)
$1.10 M(-6.7%)
Mar 2011
-
$291.00 K(+6.2%)
$1.18 M(-3.6%)
Dec 2010
$1.22 M(-150.3%)
$274.00 K(-7.4%)
$1.22 M(-129.0%)
Sep 2010
-
$296.00 K(-6.6%)
-$4.21 M(-3.8%)
Jun 2010
-
$317.00 K(-5.4%)
-$4.38 M(+25.7%)
Mar 2010
-
$335.00 K(-106.5%)
-$3.48 M(+60.4%)
Dec 2009
-$2.43 M(-161.7%)
-$5.16 M(-4067.7%)
-$2.17 M(-198.1%)
Sep 2009
-
$130.00 K(-89.3%)
$2.21 M(-31.6%)
Jun 2009
-
$1.21 M(-26.3%)
$3.23 M(-3.7%)
Mar 2009
-
$1.65 M(-311.6%)
$3.36 M(+96.1%)
Dec 2008
$3.94 M(-29.5%)
-$778.00 K(-167.5%)
$1.71 M(-31.2%)
Sep 2008
-
$1.15 M(-13.8%)
$2.49 M(+86.2%)
Jun 2008
-
$1.34 M(+6.0%)
$1.34 M(+6.0%)
Dec 2007
$5.58 M(+0.1%)
-
-
Jun 2007
-
$1.26 M(-0.3%)
$1.26 M(-0.3%)
Dec 2006
$5.58 M(+2.2%)
-
-
Jun 2006
-
$1.27 M(+58.3%)
$1.27 M(+58.3%)
Dec 2005
$5.46 M(+32.0%)
-
-
Jun 2005
-
$800.00 K(+14.6%)
$800.00 K(+14.6%)
Dec 2004
$4.13 M(+33.1%)
-
-
Jun 2004
-
$698.00 K
$698.00 K
Dec 2003
$3.10 M(-14.7%)
-
-
Dec 2002
$3.64 M(+21.2%)
-
-
Dec 2001
$3.00 M
-
-

FAQ

  • What is XTL Biopharmaceuticals annual SGA?
  • What is the all time high annual SGA for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals annual SGA year-on-year change?
  • What is XTL Biopharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals quarterly SGA year-on-year change?
  • What is XTL Biopharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals TTM SGA year-on-year change?

What is XTL Biopharmaceuticals annual SGA?

The current annual SGA of XTLB is $734.00 K

What is the all time high annual SGA for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high annual SGA is $5.58 M

What is XTL Biopharmaceuticals annual SGA year-on-year change?

Over the past year, XTLB annual SGA has changed by -$116.00 K (-13.65%)

What is XTL Biopharmaceuticals quarterly SGA?

The current quarterly SGA of XTLB is $756.00 K

What is the all time high quarterly SGA for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high quarterly SGA is $1.65 M

What is XTL Biopharmaceuticals quarterly SGA year-on-year change?

Over the past year, XTLB quarterly SGA has changed by +$587.00 K (+347.34%)

What is XTL Biopharmaceuticals TTM SGA?

The current TTM SGA of XTLB is -$633.01 M

What is the all time high TTM SGA for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high TTM SGA is -$79.37 M

What is XTL Biopharmaceuticals TTM SGA year-on-year change?

Over the past year, XTLB TTM SGA has changed by -$633.67 M (-95288.87%)